Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma
Lijie Li, Huafeng Shou, Qianqian Wang, et al.
Gene (2019) Vol. 694, pp. 76-82
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Targeting epigenetic regulators to overcome drug resistance in cancers
Nan Wang, Ting Ma, Bin Yu
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 159
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways
Nourhan M. Abdelmaksoud, Hesham A. El-Mahdy, Ahmed Ismail, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154411-154411
Closed Access | Times Cited: 56
RETRACTED ARTICLE: The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA
Chen Chen, Zhiguo Huang, Xiaoye Mo, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 80
Non-Coding RNAs as Prognostic Markers for Endometrial Cancer
Roberto Piergentili, Simona Zaami, Anna Franca Cavaliere, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 3151-3151
Open Access | Times Cited: 55
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs
Arsinoe C. Thomaidou, Panagiota Batsaki, Maria Adamaki, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8257-8257
Open Access | Times Cited: 31
Targeting drug‐tolerant cells: A promising strategy for overcoming acquired drug resistance in cancer cells
Xiao-Hai Song, Lan Yang, Xiuli Zheng, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 12
LncRNA HEIH Enhances Paclitaxel-Tolerance of Endometrial Cancer Cells via Activation of MAPK Signaling Pathway
Junliang Guo, Tian Tang, Jinhong Li, et al.
Pathology & Oncology Research (2019) Vol. 26, Iss. 3, pp. 1757-1766
Closed Access | Times Cited: 35
Targeting histone demethylase KDM5B for cancer treatment
Yun-Dong Fu, Ming-Jie Huang, Jia–Wen Guo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112760-112760
Closed Access | Times Cited: 30
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review
Amélia Favier, G Röcher, Annette K. Larsen, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 1137-1137
Open Access | Times Cited: 23
The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review
Klaudia Klicka, Tomasz M. Grzywa, Alicja Klinke, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3393-3393
Open Access | Times Cited: 21
MicroRNA‑29c‑3p acts as a tumor suppressor gene and inhibits tumor progression in hepatocellular carcinoma by targeting TRIM31
Tao� Lv, Li Jiang, Lingxiang Kong, et al.
Oncology Reports (2020)
Open Access | Times Cited: 22
Integrative analyses of prognosis, tumor immunity, and ceRNA network of the ferroptosis-associated gene FANCD2 in hepatocellular carcinoma
Zhihao Yang, Yaoshu Song, Ya Li, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 13
MicroRNA‑34b expression enhances chemosensitivity of endometrial cancer cells to paclitaxel
Megumi Yanokura, Kouji Banno, Daisuke Aoki
International Journal of Oncology (2020)
Open Access | Times Cited: 19
Pathogenic and Therapeutic Role of H3K4 Family of Methylases and Demethylases in Cancers
Aman Kumar, Niti Kumari, Nayudu Nallabelli, et al.
Indian Journal of Clinical Biochemistry (2019) Vol. 34, Iss. 2, pp. 123-132
Open Access | Times Cited: 19
E2F1 Reduces Sorafenib’s Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis
Zhifeng Ma, Ting Zhu, Haiyong Wang, et al.
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 4
Expression and clinical significance of KDM5A, KDM5B, and FOXO1 in endometrial cancer
Yao Gao, Jun Gao
Polish Journal of Pathology (2024) Vol. 75, Iss. 2, pp. 83-96
Open Access | Times Cited: 1
LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B
Jie Li, Fang Hou, Zhenghua Teng, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 1
MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study.
Ennio Nano, Francesco Reggiani, Adriana Amaro, et al.
(2024)
Open Access | Times Cited: 1
Micro‐RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy
Jing‐Xuan Xu, Yan Yang, Xu Zhang, et al.
The Anatomical Record (2020) Vol. 304, Iss. 2, pp. 342-352
Open Access | Times Cited: 10
Analyzing the whole-transcriptome profiles of ncRNAs and predicting the competing endogenous RNA networks in cervical cancer cell lines with cisplatin resistance
Huimin Lv, Shanshan Jin, Binbin Zou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Overcoming radio-resistance in esophageal squamous cell carcinoma via hypermethylation of PIK3C3 promoter region mediated by KDM5B loss
Xiaobo Wang, Min Gu, Yongjian Ju, et al.
Journal of Radiation Research (2022) Vol. 63, Iss. 3, pp. 331-341
Open Access | Times Cited: 6
Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
Barbara Marengo, Alessandra Pulliero, Maria Valeria Corrias, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 2, pp. 107-107
Open Access | Times Cited: 7
Construction of miRNA-mRNA Regulatory Network and Prognostic Signature in Endometrial Cancer
Rui Sun, Jinhui Liu, Sipei Nie, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 2363-2378
Open Access | Times Cited: 7
Advances in MiRNAs Involved in Endometrial Carcinoma
Yan He, Ke Liao, Hua Peng, et al.
Combinatorial Chemistry & High Throughput Screening (2024) Vol. 28, Iss. 1, pp. 3-11
Closed Access
ETS homologous factor, controlled by lysine-specific demethylase 5B, suppresses clear cell renal cell carcinoma by inducing Filamin-B
Fang Wang, Jiangbo Huang, Shun Zeng, et al.
Gene (2024) Vol. 927, pp. 148702-148702
Closed Access
Page 1 - Next Page

Scroll to top